Abstract
We focused our studies on the leech, Hirudo medicinalis. This invertebrate has a relative anatomical simplicity and is a reliable model for studying a variety of basic events, such as tissue repair, which has a striking similarity with vertebrate responses. Hirudo is also a good invertebrate model to test the actions of drugs and gene products, since the responses evoked by the different stimuli are clear and easily detectable due to their small size and anatomical simplicity. Here we review the use of this invertebrate model to investigate muscle regeneration and the role of hematopoietic stem cells in this process. Our recent data, summarized in this review, demonstrate that the injection of an appropriate combination of the matrigel biopolymer supplemented with Vascular Endothelial Growth Factor (VEGF) in the leech Hirudo medicinalis is a remarkably effective tool for isolating a specific population of hematopoietic/endothelial precursor cells, which in turn can differentiate in muscle cells. Thus leeches can be considered as a new emerging model for studying endothelial and hematopoietic precursors cells involved in muscle post-natal growth and regeneration processes.
Keywords: Muscle regeneration, leeches, myoendothelial cells, VEGF
Current Pharmaceutical Design
Title: The Leech: A Novel Invertebrate Model for Studying Muscle Regeneration and Diseases
Volume: 16 Issue: 8
Author(s): Annalisa Grimaldi, Serena Banfi, Cristiano Bianchi, Gabriella Greco, Gianluca Tettamanti, Douglas M. Noonan, Roberto Valvassori and Magda de Eguileor
Affiliation:
Keywords: Muscle regeneration, leeches, myoendothelial cells, VEGF
Abstract: We focused our studies on the leech, Hirudo medicinalis. This invertebrate has a relative anatomical simplicity and is a reliable model for studying a variety of basic events, such as tissue repair, which has a striking similarity with vertebrate responses. Hirudo is also a good invertebrate model to test the actions of drugs and gene products, since the responses evoked by the different stimuli are clear and easily detectable due to their small size and anatomical simplicity. Here we review the use of this invertebrate model to investigate muscle regeneration and the role of hematopoietic stem cells in this process. Our recent data, summarized in this review, demonstrate that the injection of an appropriate combination of the matrigel biopolymer supplemented with Vascular Endothelial Growth Factor (VEGF) in the leech Hirudo medicinalis is a remarkably effective tool for isolating a specific population of hematopoietic/endothelial precursor cells, which in turn can differentiate in muscle cells. Thus leeches can be considered as a new emerging model for studying endothelial and hematopoietic precursors cells involved in muscle post-natal growth and regeneration processes.
Export Options
About this article
Cite this article as:
Grimaldi Annalisa, Banfi Serena, Bianchi Cristiano, Greco Gabriella, Tettamanti Gianluca, Noonan M. Douglas, Valvassori Roberto and de Eguileor Magda, The Leech: A Novel Invertebrate Model for Studying Muscle Regeneration and Diseases, Current Pharmaceutical Design 2010; 16 (8) . https://dx.doi.org/10.2174/138161210790883417
DOI https://dx.doi.org/10.2174/138161210790883417 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Vascular Niche by Parathyroid Hormone
Current Medicinal Chemistry SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease
Current Drug Targets Gene Therapy in In Vivo Isolated Perfusion Models
Current Gene Therapy Antithrombotic Treatment in the Prevention of Ischemic Stroke
Current Drug Targets Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
Current Vascular Pharmacology Epidemiology and Costs of Hypertension-related Disorders
Current Pharmaceutical Design Recent Updates on Current and Upcoming Biomarkers for Cardiovascular Diseases
Current Pharmaceutical Design Emerging Anti-inflammatory Therapies for Atherosclerosis
Current Pharmaceutical Design The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
Current Respiratory Medicine Reviews Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design New Generation Calcium Channel Blockers in Hypertensive Treatment
Current Hypertension Reviews Heat Shock Protein-60 and Risk for Cardiovascular Disease
Current Pharmaceutical Design Myocardial Ischemia/Reperfusion Injury: Potential of TRPV1 Agonists as Cardioprotective Agents
Cardiovascular & Hematological Disorders-Drug Targets Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Current Molecular Medicine Blood Coagulation and the Risk of Atherothrombosis
Current Genomics Acute Myocarditis in Children: An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery The Metabolite Trimethylamine-N-Oxide is an Emergent Biomarker of Human Health
Current Medicinal Chemistry Pro-angiogenic Molecules for Therapeutic Angiogenesis
Current Medicinal Chemistry Medicinal Agents in the Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Guide of Hypertensive Crisis Pharmacotherapy
Cardiovascular & Hematological Disorders-Drug Targets